1. Sell S . The quest for global governance in intellectual property and public health: structural, discursive and institutional dimensions. Paper Prepared for International Studies Association Conference Montreal, Canada, 17–20 March 2004. Available at http://cyber.law.harvard.edu/blogs/gems/politicshiv/sell.pdf , last accessed 14 April 2007.
2. Sweeney K . Review of findings: Australian pharmaceutical pricing in the global context. Working Paper No. 19 (Final) Pharmaceutical Industry Project Working Paper Series. Centre for Strategic Economic Studies, Victoria University of Technology, 2004. Available at http://www.cfses.com , last accessed 14 April 2007.
3. Faunce T, Doran E, Henry D, Drahos P, Searles A, Pekarsky B, et al. Assessing the impact of the Australia–United States Free Trade Agreement on Australian and global medicines policy. Globalization Health. 2005;1:15.
4. Salkeld G, Mitchell A, Hill S . Pharmaceuticals. In: Mooney G, Scotton R, editors. Economics and Australian Health Policy. Australia: Allen and Unwin; 1998, p. 115–136.
5. Hassett KA . Price Controls and the Evolution of Pharmaceutical Markets Draft Paper American Enterprise Institute 2004. Available at https://www.who.int/intellectualproperty/news/en/Submission-Hassett.pdf , accessed 16 October 2006.